ALL KEYWORDS
Non-Hodgkin Lymphoma
Related Specialists
Showing 3 of 25
Related Fact Sheets
Related Clinical Trials
Showing 2 of 6
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma
- Lymphoma
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma
- Lymphoma
Related Departments
Showing 3 of 5